Dual Inhibitors of COX-2 and Soluble Epoxide Hydrolase (sEH) (JMMC v1n2a5) - synergy - synergy

Dual Inhibitors of COX-2 and Soluble Epoxide Hydrolase (sEH) Pages 105-114

Vijaykumar D. Nimbarte, Murtuza Hadianawala and Krishnam Raju Atcha

Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER) Hyderabad, Balanagar, Hyderabad-500037, India

DOI: http://dx.doi.org/10.12970/2308-8044.2013.01.02.5

Download PDF

Abstract: A series of novel Dual Inhibitors of COX-2 and sEH containing an N-urea substituted pyrazole as a lead for sEH inhibition have been synthesized and screened as novel analogues to reduce blood pressure elevation by acting as sEH inhibitors. The synthesized compounds having varying degrees of selectivity towards the sEH enzymes. Particularly compounds 6g and 6i emerged as the most potent sEH inhibitor displaying IC50 values of 0.114 ± 0.014 µM and 0.120 ± 0.03 µM for in-vitro sEH inhibition and the selectivity for COX-2 enzyme pave the way for discovery of novel Dual Inhibitors.

Keywords: AUDA, (1, 5)-Diarylpyrazole derivatives, Hypertension, N-Acyl, sEH inhibition, Urea, etc. Read more

  • Why Choose Synergy

    Synergy Publishers opens a portal to researchers and scholarly communities We aspire to be one of the best publishers for professional and scholarly societies. We maintain a balanced, independent editorial policy being fully committed to authors with honesty. We strive to proceed in a manner that is conducive to a sustainable future.